Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Non-cash Items: 2022-2025

  • Cellebrite DI's Non-cash Items fell 55.17% to $4.4 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $4.4 billion, marking a year-over-year decrease of 55.17%. This contributed to the annual value of $179.0 million for FY2024, which is 135.58% up from last year.
  • Latest data reveals that Cellebrite DI reported Non-cash Items of $4.4 billion as of Q2 2025, which was up 2,380.52% from $179.0 million recorded in Q4 2024.
  • In the past 5 years, Cellebrite DI's Non-cash Items ranged from a high of $16.8 billion in Q2 2022 and a low of $31.0 million during Q4 2022.
  • Over the past 3 years, Cellebrite DI's median Non-cash Items value was $4.4 billion (recorded in 2025), while the average stood at $5.9 billion.
  • As far as peak fluctuations go, Cellebrite DI's Non-cash Items skyrocketed by 145.28% in 2023, and later crashed by 55.17% in 2025.
  • Cellebrite DI's Non-cash Items (Quarterly) stood at $31.0 million in 2022, then soared by 145.28% to $76.0 million in 2023, then surged by 135.58% to $179.0 million in 2024, then plummeted by 55.17% to $4.4 billion in 2025.
  • Its Non-cash Items stands at $4.4 billion for Q2 2025, versus $179.0 million for Q4 2024 and $9.9 billion for Q2 2024.